Anti-FGF-22 Antibody

Manufactured by Antibodies.com, this affinity-purified reagent is a rabbit polyclonal antibody raised against FGF-22 (Fibroblast Growth Factor 22), generated from a synthesized peptide derived from the internal region of the human target. Supplied as a 50 µL liquid formulation at a concentration of 1 mg/mL in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, the antibody is unconjugated and of the IgG isotype, allowing flexibility for use with a wide range of secondary detection systems. Its clonality is polyclonal, which supports detection of multiple epitopes on the FGF-22 protein for robust endogenous signal across experimental systems. The antibody has been validated for Western Blot (WB), Immunohistochemistry (IHC) and Immunocytochemistry/Immunofluorescence (ICC/IF) applications, with cross-reactivity confirmed in Human, Mouse and Rat samples. Specificity is well-defined: the polyclonal preparation detects endogenous levels of FGF-22, making it a reliable choice for researchers investigating growth factor signaling, epithelial biology and related pathways. For optimal preservation, the product is shipped at 4 °C and, upon receipt, should be aliquoted and stored at –20 °C, avoiding repeated freeze/thaw cycles to maintain binding activity. Quality-controlled by affinity chromatography using an epitope-specific immunogen, this reagent is intended for research use only and is not validated for diagnostic or therapeutic applications. It is dispatched from St. Louis, MO, with an expected lead time of 6–9 business days, ensuring secure cold-chain logistics for sensitive biomolecules.